MYBPC3
Myosin-binding protein C, cardiac-type
Also known as: CMH4, cMyBP-C, FHC, MYPC3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14896
- Gene
- MYBPC3
- Ensembl
- ENSG00000134571
- Chromosome
- 11
- Canonical length
- 1274 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
1274 residues, UniProt reviewed canonical sequence.
>Q14896|MYBPC3
1 MPEPGKKPVS AFSKKPRSVE VAAGSPAVFE AETERAGVKV RWQRGGSDIS ASNKYGLATE
61 GTRHTLTVRE VGPADQGSYA VIAGSSKVKF DLKVIEAEKA EPMLAPAPAP AEATGAPGEA
121 PAPAAELGES APSPKGSSSA ALNGPTPGAP DDPIGLFVMR PQDGEVTVGG SITFSARVAG
181 ASLLKPPVVK WFKGKWVDLS SKVGQHLQLH DSYDRASKVY LFELHITDAQ PAFTGSYRCE
241 VSTKDKFDCS NFNLTVHEAM GTGDLDLLSA FRRTSLAGGG RRISDSHEDT GILDFSSLLK
301 KRDSFRTPRD SKLEAPAEED VWEILRQAPP SEYERIAFQY GVTDLRGMLK RLKGMRRDEK
361 KSTAFQKKLE PAYQVSKGHK IRLTVELADH DAEVKWLKNG QEIQMSGSKY IFESIGAKRT
421 LTISQCSLAD DAAYQCVVGG EKCSTELFVK EPPVLITRPL EDQLVMVGQR VEFECEVSEE
481 GAQVKWLKDG VELTREETFK YRFKKDGQRH HLIINEAMLE DAGHYALCTS GGQALAELIV
541 QEKKLEVYQS IADLMVGAKD QAVFKCEVSD ENVRGVWLKN GKELVPDSRI KVSHIGRVHK
601 LTIDDVTPAD EADYSFVPEG FACNLSAKLH FMEVKIDFVP RQEPPKIHLD CPGRIPDTIV
661 VVAGNKLRLD VPISGDPAPT VIWQKAITQG NKAPARPAPD APEDTGDSDE WVFDKKLLCE
721 TEGRVRVETT KDRSIFTVEG AEKEDEGVYT VTVKNPVGED QVNLTVKVID VPDAPAAPKI
781 SNVGEDSCTV QWEPPAYDGG QPILGYILER KKKKSYRWMR LNFDLIQELS HEARRMIEGV
841 VYEMRVYAVN AIGMSRPSPA SQPFMPIGPP SEPTHLAVED VSDTTVSLKW RPPERVGAGG
901 LDGYSVEYCP EGCSEWVAAL QGLTEHTSIL VKDLPTGARL LFRVRAHNMA GPGAPVTTTE
961 PVTVQEILQR PRLQLPRHLR QTIQKKVGEP VNLLIPFQGK PRPQVTWTKE GQPLAGEEVS
1021 IRNSPTDTIL FIRAARRVHS GTYQVTVRIE NMEDKATLVL QVVDKPSPPQ DLRVTDAWGL
1081 NVALEWKPPQ DVGNTELWGY TVQKADKKTM EWFTVLEHYR RTHCVVPELI IGNGYYFRVF
1141 SQNMVGFSDR AATTKEPVFI PRPGITYEPP NYKALDFSEA PSFTQPLVNR SVIAGYTAML
1201 CCAVRGSPKP KISWFKNGLD LGEDARFRMF SKQGVLTLEI RKPCPFDGGI YVCRATNLQG
1261 EARCECRLEV RVPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYBPC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 1,616 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 1,616 nTPM
- blood vessel: 8.6 nTPM
- adrenal gland: 2.8 nTPM
- spleen: 2.7 nTPM
- stomach: 2.6 nTPM
- bone marrow: 1.4 nTPM
Single-cell type
- cardiomyocytes: 2,430 nCPM
- epicardial cells: 96 nCPM
- early spermatids: 60 nCPM
- neutrophils: 32 nCPM
- late spermatids: 32 nCPM
- conjunctival goblet cells: 16 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 1.1 nTPM
- medulla oblongata: 0.6 nTPM
- cerebellum: 0.5 nTPM
- midbrain: 0.4 nTPM
- pons: 0.3 nTPM
- amygdala: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYBPC3.
Disease | AllUniProt
Conditions MYBPC3 is implicated in, by any mechanism.
- Cardiomyopathy, familial hypertrophic, 4 (CMH4) MIM:115197
- Cardiomyopathy, dilated, 1MM (CMD1MM) MIM:615396
- Left ventricular non-compaction 10 (LVNC10) MIM:615396
Disease | GeneticClinVar
1,072 pathogenic / likely-pathogenic of 4,670 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypertrophic cardiomyopathy
- Cardiovascular phenotype
- Hypertrophic cardiomyopathy 4
- Cardiomyopathy
- Left ventricular noncompaction 10
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle contraction
- cell adhesion
- heart morphogenesis
- regulation of cardiac muscle cell contraction
- regulation of muscle filament sliding
- regulation of striated muscle contraction
- sarcomere organization
- ventricular cardiac muscle tissue morphogenesis
Molecular functions
- actin binding
- ATPase activator activity
- identical protein binding
- metal ion binding
- myosin binding
- myosin heavy chain binding
- structural constituent of muscle
- titin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- MyBP-C, tri-helix bundle domain
- Striated Muscle Structural and Regulatory Protein
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Tri-helix bundle domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYBPC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYBPC3 as an antibody target. Whether an autoantibody or antibody against MYBPC3 could matter depends on whether native MYBPC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYBPC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYBPC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...